Hypera Reports Q3 Adjusted EBITDA of 782.3 Million Reais
Brazilian drugmaker Hypera reported Q3 adjusted EBITDA of 782.3 million reais, versus an IBES poll of 772 million reais.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.